Home Top Movers Galera Therapeutics Inc (GRTX) stock is rallying in the premarket on Thursday...

Galera Therapeutics Inc (GRTX) stock is rallying in the premarket on Thursday but why?

Galera Therapeutics Inc (GRTX) stock has soared 44.63% in the pre-market session on Thursday, April 29, 2021, as of this writing.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

GRTX’s stock gained 1.38% to close Wednesday’s session at $6.61. GRTX shares have fallen 46.82% over the last 12 months, and they have moved up by 1.54% in the past week. Over the past three months, the stock has lost 34.75%, while over the past six months, it has shed 48.40%.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Let’s try to find out the reason behind its pre-market surging

Read More

Updated data of Phase 1/2 pilot trial of GC4419

On April 28, 2021, Galera Therapeutics Inc. announced updated results from its Phase 1/2 pilot trial of GC4419, versus placebo.

The trial was carried out in patients with locally advanced pancreatic cancer (LAPC) who are undergoing stereotactic body radiation therapy (SBRT). The results consist of 6 months of data of all 42 patients. All results were positive with consistency.

The Company plans to report final results during the second half of 2021.

Financial results

On March 11, 2021, Galera Therapeutics, Inc. reported its financial results for the fourth quarter and year ended December 31, 2020.

Q4 2020 highlights

  • Galera reported a net loss of $20.1 million or $0.80 per share for the fourth quarter of 2020, compared to a net loss of $16.7 million, or $1.31 per share, for the same period in 2019.
  • Research and development expenses were $14.6 million in the fourth quarter of 2020compared to $13.3 million for Q4 2019.
  • General and administrative expenses were $4.3 million in the fourth quarter of 2020, compared to $2.9 million for the same period in 2019.
  • Galera had cash, cash equivalents, and short-term investments of $72.8 million, as of December 31, 2020.

FY-2020 financial highlights

  • Galera reported a net loss of $74.2 million, or $2.98 per share, for the year ended December 31, 2020, compared to a net loss of $51.9million, or $16.31 per share, for the year ended December 31, 2019.
  • Research and development expenses were $54.8 million for FY 2020 compared to $42.3 million for FY 2019.
  • General and administrative expenses were $15.7 million for the reported year compared to $8.4 million for the year ended December 31, 2019.

Participation in the investor conferences

Galera Therapeutics recently participated in Oppenheimer 31st Annual Healthcare Conference which held on Wednesday, March 17, 2021, at 1:50 p.m. ET. Mel Sorensen, M.D., President and Chief Executive Officer, presented the company.

The company also took part in a fireside chat as part of the Piper Sandler 32nd Annual Virtual Healthcare Conference, held on December 1-3, 2020.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

The recent updated improved clinical trial results are the reason behind its pre-market gains and it can further rise in the coming days.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Related News

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

F5 Networks Inc. (FFIV) stock soars during pre-market trading. Here’s to know why?

F5 Networks Inc. (FFIV) stock gained by 0.23% at the last close while the FFIV stock surged by 6.05% in the pre-market trading session....

Here is why Cerecor Inc. (CERC) stock turnaround in the after-hours on Monday?

Cerecor Inc. (CERC) shares gained 12.23% in after-hours on Monday, July 26, 2021, and closed the trading at $3.12. in the regular trading session,...

Here is why Bit Digital Inc. (BTBT) stock skyrocketed on Monday?

Bit Digital Inc. (BTBT) shares declined 10.94% in after-hours on Monday, July 26, 2021, and closed the day at $7.90. Earlier in the regular...

Why did Protagenic Therapeutics Inc. (PTIX) stock commence the new week with a negative trend?

Protagenic Therapeutics Inc. (PTIX) shares declined 13.82% in the pre-market on Monday, July 26, 2021, as of this writing. In after-hours on Friday, Protagenic...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam